Chemical similarity and biological activities

Journal of the Brazilian Chemical Society

Volumn 13, Issue 6, 2002, Pages 717-726

  Kubinyi, Hugo ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Agonists and antagonists; Chemical similarity; Hydrogen bonds; Optical enantiomers; Similarity vs. activity; Structure activity relationships

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID DERIVATIVE; ACETYLSALICYLIC ACID; ADRENALIN; ANABOLIC AGENT; ANTIBIOTIC AGENT; CARBONATE DEHYDRATASE INHIBITOR; CHLORPROMAZINE; DESIPRAMINE; DICHLORISOPRENALINE; ENZYME INHIBITOR; ESTROGEN; GAMMA AMINOPROPYLPHOSPHONOUS ACID; GESTAGEN; IMIPRAMINE; ISOPRENALINE; METHANESULFONAMIDE; NORADRENALIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROMETHAZINE; QUINAZOLINE DERIVATIVE; SALICYLAMIDE DERIVATIVE; SEX HORMONE; SULFANILAMIDE; THYROXINE; THYROXINE DERIVATIVE; TRIFLUOROMETHANESULFONAMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CHIRALITY; CONFERENCE PAPER; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; DRUG SENSITIVITY; DRUG STRUCTURE; DRUG TARGETING; HUMAN; IC 50; LIGAND BINDING; NONHUMAN; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

EID: 0036980746     PISSN: 01035053     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0103-50532002000600002     Document Type: Conference Paper

References (81)

1. Hansch, C.; Sammes, P. G.; Taylor, J. B. eds.; Comprehensive Medicinal Chemistry, Pergamon Press: Oxford, 1990.
2. th ed., John Wiley & Sons: New York, 1995.
3. Dean, P. M.ed.; Molecular Similarity in Drug Design, Blackie Academic & Professional: London, 1995.
4. Wermuth, C. G. ed.; The Practice of Medicinal Chemistry, Academic Press: London, 1996.
5. Böhm, H.-J.; Klebe, G.; Kubinyi, H.; Wirkstoffdesign. Der Weg zum Arzneimittel, Spektrum Akademischer Verlag: Heidelberg, 1996.
6. Kubinyi, H. In 3D QSAR in Drug Design. Volume II. Ligand-Protein Interactions and Molecular Similarity; Kubinyi, H.; Folkers, G.; Martin, Y. C. eds., Kluwer/ESCOM: Dordrecht, 1998, pp. 225-252; also published at Persp. Drug Design Discov. 1998, 9-11, 225.
7. Kubinyi, H. In 3D QSAR in Drug Design. Volume II. Ligand-Protein Interactions and Molecular Similarity; Kubinyi, H.; Folkers, G.; Martin, Y. C. eds., Kluwer/ESCOM: Dordrecht, 1998, pp. 225-252; also published at Persp. Drug Design Discov. 1998, 9-11, 225.
8. Hansch, C.; Bioisosterism, Intra-Science Chem. Rept. 1974, 8, 17.
9. Thornber, C. W.; Chem. Soc. Rev. 1979, 8, 563.
10. Lipinski, C. A.; Annu. Rep. Med. Chem. 1986, 21, 283.
11. Burger, A.; Prog. Drug. Res. 1991, 37, 287.
12. Patani, G. A., LaVoie, E. J.; Chem. Rev. 1996, 96, 3147.
13. Müller, K. ed.; Persp. Drug Discov. Design 1995, _3, 1.
14. Bohacek, R. S.; McMartin, C.; Guida, W. C.; Med. Res. Rev., 1996, 16, 3.
15. Veerapandian, P. ed.; Structure-Based Drug Design, Marcel Dekker: New York, 1997.
16. Babine, R. E.; Bender, S. L.; Chem. Rev. 1997, 97, 1359.
17. Gubernator, K.; Böhm, H.-J., Structure-Based Ligand Design, Methods and Principles in Medicinal Chemistry, Vol. 6, Mannhold, R.; Kubinyi, H.; Timmerman, H. eds., Wiley-VCH: Weinheim, 1998.
18. Borchardt, R. T.; Freidinger, R. M.; Sawyer, T. K.; Smith, P. L. eds., Integration of Pharmaceutical Discovery and Development. Case Histories, Pharmaceutical Biotechnology, Volume 11, Plenum Press: New York, 1998.
19. Kubinyi, H.; Curr. Opin. Drug Discov. Dev. 1998, 1, 4.
20. Kubinyi, H.; Curr. Opin. Drug Discov. Dev. 1998, 1, 16.
21. Klebe, G.; J. Mol. Med. 2000, 78, 269
22. Leung, D.; Abbenante, G.; Fairlie, D. P.; J. Med. Chem. 2000, 43, 305.
23. Dietrich, S. W.; Bolger, M. B.; Kollman, P. A.; Jorgensen, E. C.; J. Med. Chem. 1977, 20, 863.
24. Maren, T. H.; Conroy, C. W.; J. Biol. Chem. 1993, 268, 26233.
25. Froestl, W.; Furet, P.; Hall, R. G.; Mickel, S. J.; Strub, D.; von Sprecher, G.; Baumann, P. A.; Bernasconi, R.; Brugger, F.; Felner, A.; Gentsch, C.; Hauser, K.; Jaekel, J.; Karlsson, G.; Krebs, K.; Maître, L.; Marescaux, C.; Moser, P.; Pozza, M. F.; Rihs, G.; Schmutz, M.; Steinmann, M. W.; van Riezen, H.; Vassout, A.; Mondadori, C.; Olpe, H.-R.; Waldmeier, P. C.; Bittiger, H. In Perspectives in Medicinal Chemistry; Testa, B. Kyburz, E.; Fuhrer, W.; Giger, R. eds., Verlag Helvetica Chimica Acta: Basel and VCH: Weinheim, 1993, p. 259.
26. Cramer, F.; Freist, W.; Acc. Chem. Res. 1987, 20, 79.
27. Kubinyi, H. In Pharmacokinetic Optimization in Drug Research. Biological, Physicochemical, and Computational Strategies; Testa, B.; van de Waterbeemd, H.; Folkers, G.; Guy, R. eds.; Helvetica Chimica Acta and Wiley-VCH: Zürich, 2001, p. 513.
28. Loll, P. J.; Kaplan, J.; Selinsky, B. S., Axelsen, P. H.; J. Med. Chem. 1999, 42, 4714.
29. Walsh, C. T.; Fisher, S. L.; Park, I.-S.; Prahalad, M.; Wu, Z.; Curr. Biol. 1996, 3, 21.
30. Chen, J. M.; Xu, S. L.; Wawrzak, Z.; Basarab, G. S.; Jordan, D. B.; Biochemistry 1998, 37, 17735.
31. Emmett, J. C. In Membranes and Receptors, Volume 3 of Comprehensive Medicinal Chemistry. The Rational Design, Mechanistic Study and Therapeutic Application of Chemical Compounds; Hansch, C., Sammes, P. G.; Taylor, J., eds., Pergamon Press; Oxford, 1990.
32. Underwood, D. J.; Strader, C. D.; Rivero, R.; Patchett, A. A.; Greenlee, W.; Prendergast, K.; Chem. Biol. 1994, 1, 211.
33. Perlman, S.; Costa-Neto, C. M.; Miyakawa, A. A.; Schambye, H. T.; Hjorth, S. A.; Paiva, A. C. M.; Rivero, R. A.; Greenlee, W. J.; Schwartz, T. W.; Mol. Pharmacol. 1997, 51, 301.
34. Beeley, N. R. A.; Drug Discov. Today 2000, 5, 354.
35. Ooms, F.; Curr. Med. Chem. 2000, 7, 141.
36. Lauri, G.; Bartlett, P. A.; J. Comput.-Aided Mol. Design 1994, 8, 51.
37. Haubner, R.; Finsinger, D.; Kessler, H.; Angew. Chem. Int. Ed. Engl. 1997, 36, 1375.
38. Aumailley, M.; Gurrath, M.; Müller, G.; Calvete, J.; Timpl, R.; Kessler, H.; FEBS Letters 1991, 291, 50.
39. Ku, T. W.; Ali, F. E.; Barton, L. S.; Bean, J. W.; Bondinell, W. E.; Burgess, J. L.; Callahan, J. F.; Calvo, R. R.; Chen, L.; Eggleston, D. S.; Gleason, J. G.; Huffman, W. F.; Hwang, S. M.; Jakas, D. R.; Kharash, C. B.; Keenan, R. M.; Kopple, K. D.; Miller, W. M.; Newlander, K. A.; Nichols, A.; Parker, M. F.; Peishoff, C. E.; Samanen, J. M.; Uzinskas, I.; Venslavsky, J. W.; J. Am. Chem. Soc. 1993, 115, 8861.
40. Pfaff, M.; Tangemann, K.; Müller, B.; Gurrath, M.; Müller, G.; Kessler, H.; Timpl, R.; Engel, J.; J. Biol. Chem. 1994, 269, 20233.
41. Mousa, S. A.; Cheresh, D. A.; Drug Discov. Today 1997, 2, 187.
42. Samanen, J. M.; Ali, F. E.; Barton, L. S.; Bondinell, W. E.; Burgess, J. L.; Callahan, J. F.; Calvo, R. R.; Chen, W.; Chen, L.; Erhard, K.; Feuerstein, G.; Heys, R.; Hwang, S. M.; Jakas, D. R.; Keenan, R. M.; Ku, T. W.; Kwon, C.; Lee, C. P.; Miller, W. H.; Newlander, K. A.; Nichols, A.; Parker, M.; Peishoff, C. E.; Rhodes, G.; Ross, S.; Shu, A.; Simpson, R.; Takata, D.; Yellin, T. O.; Uzsinskas, I.; Venslavsky, J. W.; Yuan, C. K.; Huffman, W. F.; J. Med. Chem. 1996, 39, 4867.
43. Keenan, R. M.; Miller, W. H.; Kwon, C.; Ali, F. E.; Callahan, J. F.; Calvo, R. R.; Hwang, S. M.; Kopple, K. D.; Peishoff, C. E.; Samanen, J. M.; Wong, A. S.; Yuan, C. K.; Huffman, W. F.; J. Med. Chem. 1997, 40, 2289.
44. Bartlett, P. A.; Marlowe, C. K.; Science 1987, 235, 569.
45. Tronrud, D. E.; Holden, H. M.; Matthews, B. W.; Science 1987, 235, 571.
46. Bash, P. A.; Singh, U. C.; Brown, F. K.; Langridge, R.; Kollman, P. A.; Science 1987, 235, 574.
47. Merz, K. M.; Kollman, P. A.; J. Am. Chem. Soc. 1989, 111, 5649.
48. Morgan, B. P.; Scholtz, J. M.; Ballinger, M. D.; Zipkin, I. D.; Bartlett, P.A. Bartlett, P. A.; J. Am. Chem. Soc. 1991, 113, 297.
49. Shuman, R. T.; Rothenberger, R. B.; Campbell, C. S.; Smith, G. F.; Gifford-Moore, D. S.; Gesellchen, P. D.; Chemistry and Biology (Proceedings of the 12th American Peptide Symposium, Cambridge, MA, USA, 1991), Smith, J. A.; Rivier, J. E., ed., ESCOM Science Publishers B. V.: Leiden, 1992, p. 801.
50. Balasubramanian, N.; St. Laurent, D. R.; Federici, M. E.; Meanwell, N. A.; Wright, J. J.; Schumacher, W. A.; Seiler, S. M.; J. Med. Chem. 1993, 36, 300.
51. Klein, S. I.; Dener, J. M.; Molino, B. F.; Gardner, C. J.; D'Alisa, R.; Dunwiddie, C. T.; Kasiewski, C.; Leadley, R. J.; Bioorg. Med. Chem. Lett. 1996, 6, 2225.
52. Obst, U.; Banner, D. W.; Weber, L.; Diederich, F.; Chem. Biol. 1997, 4, 287.
53. Wolfenden, R.; Kati, W. M.; Acc. Chem. Res. 1991, 24, 209.
54. Xiang, S.; Short, S. A.; Wolfenden, R.; Carter Jr., C. W.; Biochemistry 1995, 34, 4516.
55. Clozel, J.-P.; Fischli, W.; Arzneim.-Forsch. (Drug. Res.) 1993, 43, 260.
56. Dhanaraj, V.; Dealwis, C. G.; Frazao, C.; Badasso, M.; Sibanda, B. L.; Tickle, I. J.; Cooper, J. B.; Driessen, H. P.; Newman, M.; Aguilar, C. Nature 1992, 357, 466.
57. Parker, E. M.; Grisel, D. A.; Iben, L. G.; Shapiro, R. S.; J. Neurochem. 1993, 60, 380.
58. Roderick, S. L.; Fournié-Zaluski, M. C.; Roques, B. P.; Matthews, B. W.; Biochemistry 1989, 28, 1493.
59. Roques, B. P.; Nobel, F.; Daugé, V.; Fournié-Zaluski, M.; Beaumont, A.; Pharmacol. Rev. 1993, 45, 87.
60. Hanson, D. J.; Chem. Eng. News 1991, August 12, 7.
61. Ariëns, E. J.; Soudijn, W.; Timmermans, P. B. M. W. M.; Stereochemistry and Biological Activity of Drugs, Blackwell Scientific Publishers: Oxford, 1983.
62. Smith, D. F. ed.; CRC Handbook of Stereoisomers: Therapeutic Drugs, CRC Press: Boca Raton, Florida, 1989.
63. Holmstedt, B.; Frank, H.; Testa, B.; Chirality and Biological Activity, Alan R. Liss, Inc.: New York, 1990.
64. Brown, C. ed.; Chirality in Drug Design and Synthesis, Academic Press: London, 1990.
65. Roth, H. J.; Müller, C. E.; Folkers, G.; Stereochemie & Arzneistoffe: Grundlagen - Betrachtungen - Auswirkungen, Wissenschaftliche Verlagsgesellschaft: Stuttgart, 1998.
66. Lehmann F., P. A.; Rodriguez de Miranda, J. F.; Ariëns, E. J.; Prog. Drug Res. 1976, 20, 101.
67. Ariëns, E. J.; Eur. J. Clin. Pharmacol. 1984, 26, 663.
68. Mason, S.; Trends Pharmacol. Sci. 1986, 7, 20, and further articles of other authors, pp. 60, 112, 155, 200, 227 and 281.
69. Ariëns, E. J.; Wuis, E. W.; Veringa, E. J.; Biochem. Pharmacol. 1988, 37, 9.
70. Ariëns, E. J.; Trends Pharmacol. Sci. 1993, 14, 68.
71. Testa, B.; Pharmacochem. Libr. 1993, 20, 1.
72. Stinson, S. C.; Chem. Eng. News, 1994, September 19, 38; ibid, 1995, October 09, 44.
73. Stinson, S. C.; Chem. Eng. News, 1994, September 19, 38; ibid, 1995, October 09, 44.
74. Triggle, D. J.; Drug Discov. Today 1997, 2, 138.
75. Schramm, M.; Thomas, G.; Towart, R.; Franckowiak, G.; Nature 1983, 303, 535.
76. Franckowiak, G.; Bechem, M.; Schramm, M.; Thomas, G.; Eur. J. Pharmacol. 1985, 114, 223.
77. de Tullio, P.; Delarge, J.; Pirotte, B.; Curr. Med. Chem. 1999, 6, 433.
78. Hughes, J.; Dockray, G. J.; Hill, D.; Garcia, L.; Pritchard, M. C.; Forster, E.; Toescu, E.; Woodruff, G.; Horwell, D. C.; Regul. Pept. 1996, 65, 15.
79. Beinborn, M.; Quinn, S. M.; Kopin, A. S.; J. Biol. Chem. 1998, 273, 14146.
80. Friedman, L.; Miller, J. G.; Science 1971, 172, 1044.
81. Guth, H.; Helv. Chim. Acta 1996, 79, 1559.